TVTX logo

Travere Therapeutics, Inc. (TVTX) Cash From Investing

Annual CFI:

$99.33M+$43.55M(+78.08%)
December 31, 2024

Summary

  • As of today, TVTX annual cash from investing is $99.33 million, with the most recent change of +$43.55 million (+78.08%) on December 31, 2024.
  • During the last 3 years, TVTX annual cash from investing has risen by +$236.95 million (+172.17%).
  • TVTX annual cash from investing is now at all-time high.

Performance

TVTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Quarterly CFI:

$4.85M-$36.44M(-88.25%)
June 30, 2025

Summary

  • As of today, TVTX quarterly cash from investing is $4.85 million, with the most recent change of -$36.44 million (-88.25%) on June 30, 2025.
  • Over the past year, TVTX quarterly cash from investing has dropped by -$23.76 million (-83.05%).
  • TVTX quarterly cash from investing is now -96.36% below its all-time high of $133.32 million, reached on September 30, 2023.

Performance

TVTX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

TTM CFI:

$11.96M-$23.76M(-66.52%)
June 30, 2025

Summary

  • As of today, TVTX TTM cash from investing is $11.96 million, with the most recent change of -$23.76 million (-66.52%) on June 30, 2025.
  • Over the past year, TVTX TTM cash from investing has dropped by -$237.92 million (-95.21%).
  • TVTX TTM cash from investing is now -95.21% below its all-time high of $249.88 million, reached on June 30, 2024.

Performance

TVTX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TVTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+78.1%-83.0%-95.2%
3Y3 Years+172.2%+112.4%-64.8%
5Y5 Years+400.1%-92.8%-81.8%

TVTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+172.2%-96.4%+106.0%-95.2%+111.6%
5Y5-Yearat high+172.2%-96.4%+103.9%-95.2%+103.5%
All-TimeAll-Timeat high+148.9%-96.4%+103.0%-95.2%+103.5%

TVTX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.85M(-88.3%)
$11.96M(-66.5%)
Mar 2025
-
$41.29M(+151.4%)
$35.72M(-64.0%)
Dec 2024
$99.33M(+78.1%)
-$80.31M(-274.1%)
$99.33M(-38.9%)
Sep 2024
-
$46.13M(+61.2%)
$162.68M(-34.9%)
Jun 2024
-
$28.61M(-72.7%)
$249.88M(+26.4%)
Mar 2024
-
$104.90M(+718.9%)
$197.71M(+254.5%)
Dec 2023
$55.78M(+271.3%)
-$16.95M(-112.7%)
$55.78M(+54.8%)
Sep 2023
-
$133.32M(+666.0%)
$36.02M(+141.3%)
Jun 2023
-
-$23.55M(+36.4%)
-$87.21M(+15.1%)
Mar 2023
-
-$37.04M(-0.9%)
-$102.76M(-215.7%)
Dec 2022
-$32.55M(+76.3%)
-$36.70M(-464.1%)
-$32.55M(-382.6%)
Sep 2022
-
$10.08M(+125.8%)
$11.52M(-66.1%)
Jun 2022
-
-$39.10M(-217.9%)
$33.96M(+2621.1%)
Mar 2022
-
$33.16M(+350.0%)
$1.25M(+100.9%)
Dec 2021
-$137.62M(-124.4%)
$7.37M(-77.3%)
-$137.62M(+49.1%)
Sep 2021
-
$32.52M(+145.3%)
-$270.50M(+21.9%)
Jun 2021
-
-$71.81M(+32.1%)
-$346.19M(-67.6%)
Mar 2021
-
-$105.71M(+15.8%)
-$206.58M(-236.9%)
Dec 2020
-$61.33M(-408.7%)
-$125.51M(-190.7%)
-$61.33M(-193.3%)
Sep 2020
-
-$43.17M(-163.7%)
$65.76M(-42.0%)
Jun 2020
-
$67.80M(+71.4%)
$113.40M(+60.1%)
Mar 2020
-
$39.55M(+2403.2%)
$70.83M(+256.6%)
Dec 2019
$19.86M(+109.8%)
$1.58M(-64.6%)
$19.86M(+165.1%)
Sep 2019
-
$4.46M(-82.3%)
-$30.52M(+84.5%)
Jun 2019
-
$25.23M(+321.1%)
-$196.53M(-1.4%)
Mar 2019
-
-$11.41M(+76.6%)
-$193.85M(+4.6%)
Dec 2018
-$203.29M(-545.8%)
-$48.80M(+69.8%)
-$203.29M(-31.5%)
Sep 2018
-
-$161.54M(-678.9%)
-$154.59M(-3344.3%)
Jun 2018
-
$27.91M(+233.8%)
$4.76M(-76.9%)
Mar 2018
-
-$20.85M(>-9900.0%)
$20.63M(-54.8%)
Dec 2017
$45.60M
-$103.00K(+95.3%)
$45.60M(-40.2%)
Sep 2017
-
-$2.19M(-105.0%)
$76.29M(+5.5%)
Jun 2017
-
$43.77M(+961.0%)
$72.31M(+198.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
$4.13M(-86.5%)
$24.25M(+133.9%)
Dec 2016
$10.37M(+112.9%)
$30.59M(+595.9%)
$10.37M(+108.6%)
Sep 2016
-
-$6.17M(-43.7%)
-$120.68M(-90.4%)
Jun 2016
-
-$4.29M(+56.0%)
-$63.39M(-4.8%)
Mar 2016
-
-$9.76M(+90.3%)
-$60.50M(+24.9%)
Dec 2015
-$80.60M(-116.3%)
-$100.46M(-296.5%)
-$80.60M(-469.2%)
Sep 2015
-
$51.12M(+3751.8%)
$21.83M(+169.6%)
Jun 2015
-
-$1.40M(+95.3%)
-$31.35M(+12.9%)
Mar 2015
-
-$29.86M(-1616.0%)
-$36.01M(+3.4%)
Dec 2014
-$37.26M(-589.2%)
$1.97M(+195.5%)
-$37.26M(+1.9%)
Sep 2014
-
-$2.06M(+66.0%)
-$37.97M(+8.0%)
Jun 2014
-
-$6.06M(+80.5%)
-$41.26M(-17.2%)
Mar 2014
-
-$31.11M(-2561.5%)
-$35.21M(-551.3%)
Dec 2013
-$5.41M(-218.1%)
$1.26M(+123.6%)
-$5.41M(+18.9%)
Sep 2013
-
-$5.36M(>-9900.0%)
-$6.67M(-407.1%)
Jun 2013
-
-$8600.00(+99.3%)
-$1.32M(-0.7%)
Mar 2013
-
-$1.31M(>-9900.0%)
-$1.31M(>-9900.0%)
Dec 2012
-$1.70M(>-9900.0%)
-
-
Nov 2011
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2011
-
$0.00(0.0%)
$0.00(0.0%)
May 2011
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2010
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
$0.00(0.0%)
May 2010
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2010
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2009
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2009
-
$0.00(0.0%)
$0.00(0.0%)
May 2009
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Nov 2008
-
$0.00(0.0%)
$0.00(0.0%)
Aug 2008
-
$0.00(0.0%)
$0.00(0.0%)
May 2008
-
$0.00
$0.00
Feb 2008
$0.00
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Travere Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Travere Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of TVTX is $99.33M

What is the all-time high annual cash from investing for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual cash from investing is $99.33M

What is Travere Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, TVTX annual cash from investing has changed by +$43.55M (+78.08%)

What is Travere Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of TVTX is $4.85M

What is the all-time high quarterly cash from investing for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly cash from investing is $133.32M

What is Travere Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, TVTX quarterly cash from investing has changed by -$23.76M (-83.05%)

What is Travere Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of TVTX is $11.96M

What is the all-time high TTM cash from investing for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM cash from investing is $249.88M

What is Travere Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, TVTX TTM cash from investing has changed by -$237.92M (-95.21%)
On this page